Logo image
Prevalence of sporadic inclusion body myositis in Western Australia
Journal article   Peer reviewed

Prevalence of sporadic inclusion body myositis in Western Australia

B.A. Phillips, P.J. Zilko and F.L. Mastaglia
Muscle & Nerve, Vol.23(6), pp.970-972
2000
url
Link to Published Version *Subscription may be requiredView

Abstract

A 10-year retrospective review was conducted to ascertain the prevalence of inclusion body myositis (IBM) in Western Australia. Seventeen patients with sporadic IBM aged 45–90 years were identified and the prevalence of IBM was calculated to be 9.3 × 10−6. The prevalence was higher in men (10.9 × 10−6) than in women (7.7 × 10−6). The mean age of onset of IBM was 56.6 years, and the mean delay between onset of symptoms and diagnosis was 4.4 years. The age-adjusted prevalence over the age of 50 years was 35.3 × 10−6. The results suggest a higher prevalence of IBM than has previously been reported.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.106 Rheumatology
1.106.1684 Dermatomyositis
Web Of Science research areas
Clinical Neurology
Neurosciences
ESI research areas
Neuroscience & Behavior
Logo image